These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 25612606
1. Heme oxygenase-1 restores impaired GARPCD4⁺CD25⁺ regulatory T cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated T lymphocytes. Liu Y, Zhao X, Zhong Y, Meng K, Yu K, Shi H, Wu B, Tony H, Zhu J, Zhu R, Peng Y, Mao Y, Cheng P, Mao X, Zeng Q. Cell Physiol Biochem; 2015; 35(2):553-70. PubMed ID: 25612606 [Abstract] [Full Text] [Related]
2. Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study. Zhu ZF, Meng K, Zhong YC, Qi L, Mao XB, Yu KW, Zhang W, Zhu PF, Ren ZP, Wu BW, Ji QW, Wang X, Zeng QT. PLoS One; 2014; 9(2):e88775. PubMed ID: 24558424 [Abstract] [Full Text] [Related]
3. Impairment of Circulating CD4⁺CD25⁺GARP⁺ regulatory T cells in patients with acute coronary syndrome. Meng K, Zhang W, Zhong Y, Mao X, Lin Y, Huang Y, Lang M, Peng Y, Zhu Z, Liu Y, Zhao X, Yu K, Wu B, Ji Q, Zeng Q. Cell Physiol Biochem; 2014; 33(3):621-32. PubMed ID: 24603196 [Abstract] [Full Text] [Related]
4. CD4+ CD25+ GARP+ regulatory T cells display a compromised suppressive function in patients with dilated cardiomyopathy. Wei Y, Yu K, Wei H, Su X, Zhu R, Shi H, Sun H, Luo Q, Xu W, Xiao J, Zhong Y, Zeng Q. Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945 [Abstract] [Full Text] [Related]
5. Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus. Nookala S, Mukundan S, Fife A, Alagarsamy J, Kotb M. Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30224551 [Abstract] [Full Text] [Related]
6. [Changes of Foxp3(+); regulatory T cells in patients with acute coronary syndrome]. Zhao Z, Qi YZ, Yuan ZY, Cheng ML, Ji YQ, Yang XB. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Aug; 27(8):893-5. PubMed ID: 21806889 [Abstract] [Full Text] [Related]
7. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome. Lü CX, Xu RD, Cao M, Wang G, Yan FQ, Shang SS, Wu XF, Ruan L, Quan XQ, Zhang CT. Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638 [Abstract] [Full Text] [Related]
8. The Th17/Treg imbalance in patients with acute coronary syndrome. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH. Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918 [Abstract] [Full Text] [Related]
9. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Mor A, Luboshits G, Planer D, Keren G, George J. Eur Heart J; 2006 Nov; 27(21):2530-7. PubMed ID: 16954132 [Abstract] [Full Text] [Related]
10. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D. Proc Natl Acad Sci U S A; 2009 Aug 11; 106(32):13439-44. PubMed ID: 19666573 [Abstract] [Full Text] [Related]
11. Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes. Lin YZ, Lu SH, Lu ZD, Huang Y, Shi Y, Liu L, Wang XY, Ji QW. Mediators Inflamm; 2013 Aug 11; 2013():764082. PubMed ID: 24385687 [Abstract] [Full Text] [Related]
12. Changes of naturally occurring CD4(+)CD25(+) FOXP3(+) regulatory T cells in patients with acute coronary syndrome and the beneficial effects of atorvastatin treatment. Wang ZX, Wang CQ, Li XY, Ding Y, Feng GK, Jiang XJ. Int Heart J; 2015 Aug 11; 56(2):163-9. PubMed ID: 25740578 [Abstract] [Full Text] [Related]
13. Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. Elkord E, Abd Al Samid M, Chaudhary B. Oncotarget; 2015 Aug 21; 6(24):20026-36. PubMed ID: 26343373 [Abstract] [Full Text] [Related]
14. Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1. Xia ZW, Xu LQ, Zhong WW, Wei JJ, Li NL, Shao J, Li YZ, Yu SC, Zhang ZL. Am J Pathol; 2007 Dec 21; 171(6):1904-14. PubMed ID: 17991714 [Abstract] [Full Text] [Related]
15. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N. Br J Dermatol; 2008 Jun 21; 158(6):1197-209. PubMed ID: 18410422 [Abstract] [Full Text] [Related]
16. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis. Zhong Y, Tang H, Wang X, Zeng Q, Liu Y, Zhao XI, Yu K, Shi H, Zhu R, Mao X. Clin Exp Immunol; 2016 Mar 21; 183(3):452-68. PubMed ID: 26452441 [Abstract] [Full Text] [Related]